Search research articles
Contact Us
Filters
Showing results (1-10 of 176) with videos related to
Page
of 18
Sort By:
Atherosclerosis
|
March 30, 2011
Regulation of proprotein convertase subtilisin/kexin type 9: therapeutical perspectives
Dick C Chan
European Journal of Preventive Cardiology
|
March 6, 2024
Therapeutic inhibition of angiopoietin-like protein 3 for hypertriglyceridaemia and residual risk of ASCVD: beginning of the end or end of the beginning?
Gerald F Watts, Dick C Chan
Metabolism: Clinical and Experimental
|
September 28, 2011
Postprandial lipoprotein metabolism in familial hypercholesterolemia: thinking outside the box
Dick C Chan, Gerald F Watts
Current Vascular Pharmacology
|
January 29, 2008
Pharmacological regulation of dyslipoproteinaemia in insulin resistant states
Dick C Chan, Gerald F Watts
Expert Opinion on Pharmacotherapy
|
July 16, 2010
Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies
Dick C Chan, Gerald F Watts
Atherosclerosis. Supplements
|
May 11, 2010
Mechanisms for therapeutic correction of dyslipidaemia in insulin resistance and diabetes
Gerald F Watts, Dick C Chan
Clinical Laboratory
|
September 8, 2006
Recent advances in the investigation of lipoprotein metabolism using tracer methodology
Dick C Chan, Gerald F Watts
Diabetes
|
January 26, 2013
Novel insights into the regulation of postprandial lipemia by glucagon-like peptides: significance for diabetes
Gerald F Watts, Dick C Chan
Current Opinion in Lipidology
|
January 27, 2010
Nutrition and metabolism: new studies of the effects of diets and exercise on lipid and lipoprotein metabolism
Dick C Chan, Gerald F Watts
European Heart Journal
|
March 4, 2025
Reaching for the stars: a wider perspective for designing future cardiovascular outcome trials of triglyceride-lowering therapies
Gerald F Watts, Dick C Chan
Page
of 18
Search research articles
Search
Showing results (1-10 of 176) with videos related to
Sort By:
Page
of 18
Atherosclerosis
|
March 30, 2011
Regulation of proprotein convertase subtilisin/kexin type 9: therapeutical perspectives
Dick C Chan
European Journal of Preventive Cardiology
|
March 6, 2024
Therapeutic inhibition of angiopoietin-like protein 3 for hypertriglyceridaemia and residual risk of ASCVD: beginning of the end or end of the beginning?
Gerald F Watts, Dick C Chan
Metabolism: Clinical and Experimental
|
September 28, 2011
Postprandial lipoprotein metabolism in familial hypercholesterolemia: thinking outside the box
Dick C Chan, Gerald F Watts
Current Vascular Pharmacology
|
January 29, 2008
Pharmacological regulation of dyslipoproteinaemia in insulin resistant states
Dick C Chan, Gerald F Watts
Expert Opinion on Pharmacotherapy
|
July 16, 2010
Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies
Dick C Chan, Gerald F Watts
Atherosclerosis. Supplements
|
May 11, 2010
Mechanisms for therapeutic correction of dyslipidaemia in insulin resistance and diabetes
Gerald F Watts, Dick C Chan
Clinical Laboratory
|
September 8, 2006
Recent advances in the investigation of lipoprotein metabolism using tracer methodology
Dick C Chan, Gerald F Watts
Diabetes
|
January 26, 2013
Novel insights into the regulation of postprandial lipemia by glucagon-like peptides: significance for diabetes
Gerald F Watts, Dick C Chan
Current Opinion in Lipidology
|
January 27, 2010
Nutrition and metabolism: new studies of the effects of diets and exercise on lipid and lipoprotein metabolism
Dick C Chan, Gerald F Watts
European Heart Journal
|
March 4, 2025
Reaching for the stars: a wider perspective for designing future cardiovascular outcome trials of triglyceride-lowering therapies
Gerald F Watts, Dick C Chan
Page
of 18